February 2017

Letter from the Editor

February 1, 2017

Creating an experience What do customers want? This is a question every CEO and C-suite executive is asking themselves more and more frequently. How they respond to this question is what can set one company apart from its competitors. Among the topics explored in this month’s cover story are customers’ shifting expectations and how companies […]

Upfront

February 1, 2017

Trends in Biopharma Innovation Over the last 20 years, a total of 667 innovative biopharmaceuticals have launched in the United States, finds a new report from QuintilesIMS. The characteristics of biopharmaceutical innovation have evolved in some respects over the past two decades. Most notably, drugs for the treatment of patients with cancer have increased their […]

Innovator’s Corner

February 1, 2017

Gene Therapy for Better Sight Kathy High, M.D., President and Chief Scientific Officer at Spark Therapeutics, talks about the company’s gene therapy for inherited retinal diseases. Thanks to a renewed focus on gene therapy, researchers are uncovering new ways to treat diseases where no therapies exist.  (See September 2016, PharmaVOICE.) Spark Therapeutics has built a […]

HealthTech

February 1, 2017

Google Trains AI to Spot Diabetic Retinopathy Trendwatch: From eye sight to brain injuries, technology enables better care. A few years ago, Google technologies began working on ways to improve the diabetic retinopathy (DR) screening process, specifically by taking advantage of recent advances in machine learning and computer vision. Since the disease is most readily […]

Last Word

February 1, 2017

A Code of Ethics Mike Rea, CEO of IDEA Pharma, talks about the need for a unifying code of ethics for the pharmaceutical industry. PV: Why do you believe a “Code of Ethics” is necessary for the pharmaceutical industry? Rea: I think the first reason is that there isn’t one. That, for me, creates a […]

C-Suite Outlook: Leading Through Extraordinary Change

February 1, 2017

Sustaining Value According to Deloitte, life-sciences companies are evolving their business models from product development through manufacturing and distribution, to move “beyond the pill”  and to engage more fully with providers and patients throughout the product lifecycle and “transform what is possible.” Recent figures indicate these efforts may be starting to pay off. The current […]

The Creative Process

February 1, 2017

As challenging as creating a great piece of marketing is, over the years some pharma brands have still managed to nail it. According to a 2016 AdWeek CMO report, there are several examples of award-winning, but most importantly, memorable campaigns over the years that have successfully boosted brand recognition and as a result increased product […]

The Next Generation of Cancer Immunotherapy

February 1, 2017

Researchers and drug developers are gaining a better understanding of the immune system and how to better target cancer; as a result, immuno-oncology continues to be a key area of anticancer drug development. Researchers over the last few years have found that the immune system has the capability to detect and destroy abnormal cells, but […]

Update on Zika Research

February 1, 2017

First identified in Uganda in 1947, the Zika virus over the past two years has rapidly spread through Asia, the South Pacific, Hawaii, South America, Central America, and the Caribbean. In 2016, active local mosquito-borne transmission began to occur in North America, specifically in Florida and Texas. According to the World Health Organization (WHO), as […]

Rare Disease Day Turns Spotlight on Research

February 1, 2017

On the last day in February, hundreds of patients’ groups from around the world will hold a host of activities to raise awareness about rare diseases. The international 10th annual Rare Disease Day, which is coordinated by the European Organization for Rare Diseases (EURORDIS), seeks to help the public understand how rare diseases impact people’s […]

SHOWCASE FEATURE: Outsourcing: The Outsourcing Big Picture

February 1, 2017

Outsourcing is now firmly entrenched in the pharma industry. While pharmaceutical companies have been outsourcing back-office activities for many years now, they are increasingly turning to external partners for research and development activities that traditionally were retained in-house. Today, the pharmaceutical and biotech industry has the highest level of R&D outsourcing across all high-technology industries, […]

Partnering for More Impactful Patient Recruitment Services

February 1, 2017

Sponsors of global clinical trials increasingly need a strategic partner for their patient enrollment challenges, as opposed to enlisting an array of outsourced tactical vendors through a standard RFP process. Why have such partnerships become critical for on-time trial completion? There are a number of reasons. In general, the industry’s standard approach to recruitment is […]

Smart Will Win!

February 1, 2017

The more this industry changes, the more it stays the same. The companies that apply their intelligence to winning the transactional nature of our business will ultimately succeed. Whether you study the pharmaceutical and biotech industry from the top down or the bottom up, you will find that applying the good business principles that have […]

An Outsourcing Evolution: Why Improving Yesterday’s Model Addresses Tomorrow’s Needs

February 1, 2017

Under the traditional model for drug delivery and commercialization, there are many opportunities for patients to slip through the cracks. In the rare disease sector specifically, therapies typically flow through a half-dozen disjointed, uncoordinated middlemen, including wholesalers, distributors, hubs, specialty pharmacies, and healthcare providers before they get to a patient. It’s no wonder then that […]

3-D Outsourcing: The Key to Improved Product Launches

February 1, 2017

Put yourself in this situation: You are the director of operations at a growing biotech company. It is either your first product launch or your previous product launches have been slow, inefficient and costly. It is up to you to improve commercialization by streamlining processes and using limited resources more effectively. You have three options: […]

Speak Out

February 1, 2017

Maximizing Patient Recruitment in Rare Disease Research Creating a pharmaceutical develop- ment program for the treatment of a rare disease is challenging. From re-cruiting and retaining patients and investi- gators, through to regulatory uncertainties and limited understanding of the natural history of the proposed indication due to few observational trials studying disease progression, there are […]

FEEDBACK